In fact, eNOS-deficient mice exhibit an accelerated hepatic inflammatory response, while pharmacologically improving NO/cGMP signaling prevents hepatic inflammation in MASLD models [48]. This evidence concerns the gene NOS3 and metabolic dysfunction-associated steatotic liver disease.